Theranexus Société Anonyme (EPA:ALTHX)
France · Delayed Price · Currency is EUR 2.620
+0.100 (3.97%)
Sep 5, 2025, 5:35 PM CET
EPA:ALTHX Revenue
In the year 2024, Theranexus Société Anonyme had annual revenue of 2.28M EUR with 670.55% growth. Theranexus Société Anonyme had revenue of 70.09K in the half year ending December 31, 2024, with 3,021.83% growth.
Revenue
2.28M
Revenue Growth
+670.55%
P/S Ratio
9.80
Revenue / Employee
228.34K
Employees
10
Market Cap
22.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.28M | 1.99M | 670.55% |
| Dec 31, 2023 | 296.33K | -118.57K | -28.58% |
| Dec 31, 2022 | 414.90K | 414.30K | 68,819.93% |
| Dec 31, 2021 | 602.00 | -294.01K | -99.80% |
| Dec 31, 2020 | 294.61K | -269.24K | -47.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 10.59M |
| Virbac | 1.40B |